异生菌化合物对孕前的影响以及潜在的机制
Miaoliang Wu1,2, Fuhui Yan1,2, Qian Liu2
1The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan 523808, China.
环境中的毒素,特别是内分泌干扰剂,可能会引发妊娠前 (PE),这是一个严重的妊娠状况. 本综述探讨了外源化学物质和PE之间的联系,旨在防止对母亲和胎儿的不良结果.
科学领域:
- 环境健康 环境健康
- 产科 产科 产科 产科 产科
- 毒理学 毒理学 毒理学
背景情况:
- 孕前 (PE) 是一种妊娠并发症,20周后的特征是新发高血压和白色素尿或末端器官损伤.
- 孕前期显著增加了孕产妇和胎儿的发病率和死亡率,造成了相当大的社会负担.
- 新出现的证据表明,环境中的异生菌化合物,特别是内分泌干扰物,可能在PE发展中发挥作用,尽管机制尚不清楚.
研究的目的:
- 审查外源化学物质在诱导子宫前中的作用.
- 阐明环境因素导致PE的潜在机制.
- 为改善预防策略提供先孕的环境病因学的前景.
主要方法:
- 对调查环境化学物质暴露与产前之间的关联的研究进行文献综述.
- 对拟议的生物途径的分析,将异生菌与PE病原体联系起来.
- 综合目前对PE环境病因学的理解.
主要成果:
- 对某些异生菌,包括内分泌干扰剂的环境暴露越来越多地与孕前的发展有关.
- 潜在的机制包括胎盘功能障碍,螺旋动脉改造受损和氧化应激.
- 了解这些途径对于识别环境风险因素至关重要.
结论:
- 外源性化学物质暴露是产前病病因学的重要,但尚未研究的环境因素.
- 进一步研究化学诱导PE的机制对于制定有效的预防措施至关重要.
- 解决环境因素可能会提供新的策略,以减少先孕的全球负担.
更多相关视频
12:02Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
10:44A Plate-based Cytotoxicity Assay for the Assessment of Rat Placental Natural Killer Cell Cytolytic Function
Published on: June 2, 2019
相关概念视频
Teratogenicity
Hormonal Regulation
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Physiological Barriers
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
Hypertension III: Clinical Manifestations and Diagnostic Studies
